Structure of Pravastatin Sodium
CAS No.: 81131-70-6
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Pravastatin Sodium is a competitive HMG-CoA reductase inhibitor with IC50 value of 5.6 μM.
Synonyms: CS-514 sodium; Pravastatin (sodium salt)
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 81131-70-6 |
Formula : | C23H35NaO7 |
M.W : | 446.51 |
SMILES Code : | O=C([O-])C[C@H](O)C[C@H](O)CC[C@H]1[C@@H](C)C=CC2=C[C@@H](O)C[C@H](OC([C@@H](C)CC)=O)[C@]12[H].[Na+] |
Synonyms : |
CS-514 sodium; Pravastatin (sodium salt)
|
MDL No. : | MFCD00887601 |
InChI Key : | VWBQYTRBTXKKOG-IYNICTALSA-M |
Pubchem ID : | 16759173 |
GHS Pictogram: |
![]() ![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H351-H361 |
Precautionary Statements: | P280-P305+P351+P338 |
In Vitro:
Concentration | Treated Time | Description | References |
Acta2R149C/+ SMCs | 250 nM | 72 hours | decreased expression of Atf4 and Klf4 and KLF4 activity and prevented augmented phenotypic modulation | PMC10393072 |
iPSC-ECs | 1 μM | 24 hours | Pravastatin significantly increased cell migration, proliferation, and the ability to form cord-like structures, while significantly reducing apoptosis. | PMC4381134 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
mice | Acta2R149C/+Apoe−/− mice | drinking water | 5 mg/kg | every other day for 28 days | lowered circulating serum lipid levels to a similar extent in both genotypes and prevented the increased plaque burden in Acta2R149C/+Apoe?/? male mice when compared to similarly treated Apoe?/? mice | PMC10393072 |
Mice | Hindlimb ischemia model | Intraperitoneal injection | 4 mg/kg | Immediately after SCI and every other day until the experiments were terminated | Pravastatin significantly increased hindlimb reperfusion, but this effect was blocked by the NO synthase inhibitor L-NAME. | PMC4381134 |
Mice | Slco1b2−/− mice and NASH model | Intravenous injection | 4 mg/kg bw | Every other day for 38 days | To investigate the synergistic effect of Oatp1b2 genetic loss and NASH on pravastatin disposition. Results showed that the combination of Oatp1b2 genetic loss and NASH caused a significant increase in pravastatin plasma and muscle concentrations. | PMC4065643 |
Swiss mice | Amyloidosis induction model | Intraperitoneal injection | 4 mg/kg bw | Every other day for 38 days | To study the effect of Pravastatin on amyloidogenesis, results showed that high-dose Pravastatin may have a mild amyloid-protective effect in the short term | PMC1754113 |
Mice | DSS-induced colitis model | Oral | 30 mg/kg | once daily for 4 days | To investigate the impact of colitis on the in vivo clearance of Pravastatin, results showed no significant effect of colitis on Pravastatin clearance. | PMC6976992 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00982189 | HIV Infection ... More >> Cardiovascular Disease Risk Less << | Not Applicable | Completed | - | United States, Minnesota ... More >> Hennepin County Medical Center Minneapolis, Minnesota, United States, 55415 Less << |
NCT01857921 | Coronary Artery | Not Applicable | Unknown | October 2016 | Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: Myeong Ki Hong, MD, PhD 82-2-2228-8460 mkhong61@yuhs.ac Less << |
NCT00697203 | Dyslipidemia | Phase 2 | Completed | - | - |
NCT00982189 | - | Completed | - | - | |
NCT03131973 | Rheumatoid Arthritis | Phase 1 | Completed | - | United States, Texas ... More >> PPD Development, LP Austin, Texas, United States, 78744 Less << |
NCT00384618 | Chronic Kidney Disease | Phase 4 | Terminated | - | Netherlands ... More >> VU University Medical Center Amsterdam, North Holland, Netherlands, 1007 MB Less << |
NCT02841774 | HIV Infection ... More >> Coronary Heart Disease Less << | Phase 2 | Recruiting | March 2019 | United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Matthew Feinstein, MD matthewjfeinstein@northwestern.edu Principal Investigator: Matthew Feinstein, MD Less << |
NCT01011127 | - | Completed | - | Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less << | |
NCT01557075 | Drug-eluting Stent (DES) | Phase 4 | Unknown | August 2015 | Korea, Republic of ... More >> Hong Myeong-Ki Recruiting Seoul, Korea, Republic of Contact: Myeong-Ki Hong, MD.PhD +82 2 2228 8458 mkhong61@yuhs.ac Contact: Byeong-Keuk Kim, MD.PhD +82 2 2228 8465 kimbk@yuhs.ac Principal Investigator: Myeong-Ki Hong, MD.PhD Less << |
NCT00701285 | Chronic Heart Failure | Phase 4 | Completed | - | Korea, Republic of ... More >> SEOUL St. Mary's Hospital Seoul, Seocho-Ku, Korea, Republic of, 137-040 Less << |
NCT00546559 | - | Completed | - | Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405760 Less << | |
NCT00214604 | Hyperlipoproteinemia Type III | Phase 3 | Completed | - | Norway ... More >> Research Site Oslo, Norway South Africa Research Site Cape Town, South Africa Less << |
NCT02045966 | Hepatitis C | Phase 1 | Completed | - | - |
NCT00221104 | Ischemic Stroke | Phase 3 | Completed | - | Japan ... More >> Hiroshima University Hiroshima, Japan, 734-8551 Less << |
NCT03073018 | Microalbuminuria ... More >> Cardiovascular Diseases Renal Disease Less << | Phase 3 | Completed | - | - |
NCT00221104 | - | Completed | - | - | |
NCT02871687 | Healthy Subjects | Phase 1 | Recruiting | December 2018 | United States, Massachusetts ... More >> Brigham and Women's Hospital- 221 Longwood Avenue Recruiting Boston, Massachusetts, United States, 02115 Principal Investigator: Jonathan Williams, MD Sub-Investigator: Tina Gupta, MD Less << |
NCT02155530 | Coronary Artery Disease | Not Applicable | Completed | - | Korea, Republic of ... More >> Severance Hospital Seoul, Korea, Republic of, 120-752 Less << |
NCT00245388 | Dyslipidemia | Phase 2 Phase 3 | Completed | - | - |
NCT01357486 | Hepatocellular Carcinoma ... More >> CHILD B Less << | Phase 2 | Completed | - | France ... More >> CH d'Abbeville Abbeville, France, 80142 CH Pays d'Aix Aix-en-provence, France, 13616 CH d'Auxerre Auxerre, France, 89011 CH de la Côte Basque Bayonne, France, 64109 AP-HP- Hôpital Jean-Verdier Bondy, France, 93143 CHU de Bordeaux Bordeaux, France, 33075 CH Duchenne Boulogne Sur Mer, France, 62321 CH de Béziers Béziers, France, 34525 AP-HP Hôpital Henri Mondor Creteil, France, 94010 CHU Le Bocage Dijon, France, 21079 CH Départemental Vendée La Roche-sur-yon, France, 85925 CH Le Mans Le Mans, France, 72037 CH de Bretagne Sud Lorient, France, 56100 Hôpital privé Jean Mermoz Lyon, France, 69008 AP-HM Hôpital de la Timone Marseille, France, 13385 CH de Meaux Meaux, France, 77104 CH Mont de Marsan Mont-de-marsan, France, 40024 CHU de Nancy Hôpital Brabois Nancy, France, 54511 CHU de Nantes Hôpital de l'Hotel Dieu Nantes, France, 44093 CHU Nîmes Nimes, France, 30029 CHR d'Orléans - Hôpital La Source Orleans, France, 45067 Groupe Hospitalier Paris Saint Joseph Paris, France, 75014 CH Perpignan Perpignan, France, 66046 CHU de Bordeaux, Hôpital du Haut Lévèque Pessac, France, 33604 CH de la Région d'Annecy Pringy, France, 74374 Centre Eugène Marquis Rennes, France, 35042 Clinique Mathilde Rouen, France, 76000 Clinique Armoricaine de Radiologie Saint Brieuc, France, 22015 CH Saint-Malo Saint Malo, France, 35400 Centre René Gauducheau CLCC Nantes Atlantique Saint-herblain, France, 44805 CH Gaston Ramon Sens, France, 89100 Centre Régional de Lutte contre le Cancer Centre Paul Strauss Strasbourg, France, 67065 Hôpitaux Universitaires de Strasbourg Hôpital civil Strasbourg, France, 67091 Hôpitaux Universitaires de Strasbourg, Hôpital Hautepierre Strasbourg, France, 67098 CHRU de Tours Tours, France, 37044 Less << |
NCT00456365 | Polycystic Kidney, Autosomal D... More >>ominant Less << | Phase 3 | Completed | - | United States, Colorado ... More >> University of Colorado at Denver and Health Sciences Center Denver, Colorado, United States, 80262 Less << |
NCT00303277 | Alzheimer's Disease ... More >> Aging Less << | Phase 4 | Completed | - | United States, Washington ... More >> VA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less << |
NCT00005117 | Heart Diseases | Not Applicable | Unknown | - | United States, Colorado ... More >> 4200 E. 9th Avenue, Box B133 Denver, Colorado, United States, 80262 Less << |
NCT00380939 | Coronary Arteriosclerosis | Phase 4 | Completed | - | - |
NCT01816997 | Diabetes | Phase 4 | Recruiting | December 2022 | Taiwan ... More >> Taipei Veterans General Hospital Recruiting Taipei, Taiwan, 11217 Contact: Harn-Shen Chen, MD, PhD 886-2-28757515 Principal Investigator: Harn-Shen Chen, MD, PhD Less << |
NCT02456844 | Rheumatoid Arthritis | Phase 1 | Completed | - | - |
NCT00456365 | - | Completed | - | - | |
NCT00549926 | Coronary Disease ... More >> Hypercholesterolemia Less << | Phase 4 | Completed | - | Japan ... More >> Yokohama City University Medical Center Yokohama, Japan Less << |
NCT00166036 | Diabetes Mellitus ... More >> Metabolic Syndrome X Hypercholesterolemia Less << | Phase 2 | Completed | - | United States, Georgia ... More >> Emory University Hospital Atlanta, Georgia, United States, 30322 Less << |
NCT02266485 | Healthy | Phase 1 | Completed | - | - |
NCT00166036 | - | Completed | - | - | |
NCT03273413 | ADPKD Autosom... More >>al Dominant Polycystic Kidney Less << | Phase 4 | Recruiting | December 2021 | United States, Colorado ... More >> University of Colorado Denver Anschutz Medical Campus Recruiting Denver, Colorado, United States, 80045 Contact: Nina Z Bispham, MS 303-724-1692 nina.bispham@ucdenver.edu Contact: Beverly Farmer, RN 303-724-7790 beverly.farmer@ucdenver.edu Principal Investigator: Michel B Chonchol, MD Less << |
NCT02484261 | Leukemia | Phase 1 | Active, not recruiting | August 2020 | United States, District of Col... More >>umbia Children's National Medical Center Washington, District of Columbia, United States, 20010 Less << |
NCT02431013 | Dyslipidemias ... More >> Peripheral Artery Disease Less << | Phase 1 | Unknown | - | Korea, Republic of ... More >> Ajou University Medical Center Recruiting Suwon, Gyeonggi, Korea, Republic of, 443-380 Contact: Doo-Yeoun Cho, MD +82-31-219-4271 dooycho@ajou.ac.kr Principal Investigator: Doo-Yeoun Cho, MD Less << |
NCT00405717 | Ischemic Heart Disease ... More >> Acute Coronary Syndromes Less << | Phase 4 | Completed | - | China, Liaoning ... More >> Northern Hospital Shenyang, Liaoning, China Less << |
NCT00433498 | Lung Cancer | Phase 3 | Completed | - | - |
NCT00631189 | Type IIa and IIb Hypercholeste... More >>rolaemia Less << | Phase 4 | Completed | - | - |
NCT00107523 | Leukemia | Phase 1 | Completed | - | United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less << |
NCT00631189 | - | Completed | - | - | |
NCT00200655 | Relapsing-remitting Multiple S... More >>clerosis Less << | Phase 3 | Completed | - | France ... More >> Nantes University Hospital Nantes, France, 44093 Less << |
NCT01004237 | Hypertension ... More >>High Cholesterol Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Gil Medical Center Incheon, Korea, Republic of, 405-760 Less << |
NCT01301066 | Dyslipidemia | Phase 4 | Completed | - | - |
NCT00654537 | Hypercholesterolemia | Phase 3 | Completed | - | - |
NCT00362206 | Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01301066 | - | Completed | - | - | |
NCT00639223 | Hypercholesterolemia ... More >> Statin-Associated Myopathy Less << | Phase 2 | Completed | - | United States, Pennsylvania ... More >> Chestnut Hill Hospital Philadelphia, Pennsylvania, United States, 19118 Less << |
NCT01515813 | HIV-1 Infection | Phase 2 | Withdrawn(On 05/08/12, team wo... More >>rking on revising protocol and re-open study under version 2.0) Less << | December 2014 | United States, California ... More >> UCLA CARE Center CRS (601) Los Angeles, California, United States, 90095 Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States, 90502 United States, Missouri Washington University CRS (2101) St. Louis, Missouri, United States, 63110 United States, North Carolina Unc Aids Crs (3201) Chapel Hill, North Carolina, United States, 27514 Duke University Medical Center Adult CRS (1601) Durham, North Carolina, United States, 27710 Regional Center for Infectious Disease, Wendover Medical Center CRS (3203) Greensboro, North Carolina, United States, 27401 United States, Ohio The Ohio State University AIDS CRS (2301) Colombus, Ohio, United States, 43210 United States, Tennessee Vanderbilt Therapeutics CRS (3652) Nashville, Tennessee, United States, 37232 United States, Texas Houston AIDS Research Team CRS (31473) Houston, Texas, United States, 77030 Less << |
NCT00147797 | - | Completed | - | France ... More >> Department of Pharmacology and INSERM U652, Hôpital Européen Georges Pompidou Paris, France, 75015 Less << | |
NCT00639223 | - | Completed | - | - | |
NCT00257686 | Hypercholesterolemia or Combin... More >>ed Dyslipidemia Less << | Phase 3 | Completed | - | - |
NCT01845428 | Nephrotic Syndrome ... More >> Hyperlipidemia Less << | Phase 1 | Completed | - | United States, North Carolina ... More >> Unc Kidney Center Chapel Hill, North Carolina, United States, 27599-7155 Less << |
NCT00843661 | HIV Hyperlipi... More >>demia HIV Infections Less << | Phase 4 | Unknown | July 2012 | Italy ... More >> Ospedale di Circolo and Fondazione Macchi Recruiting Varese, Italy, 21100 Contact: Anna Maria Grandi, MD +390332278403 amgrandi@libero.it Less << |
NCT00177580 | Schizophrenia ... More >> Schizoaffective Disorder Less << | Phase 4 | Completed | - | United States, Pennsylvania ... More >> Western Psychiatric Institute & Clinic Pittsburgh, Pennsylvania, United States, 15213 Less << |
NCT00529178 | Hypercholesterolemia | Phase 4 | Completed | - | - |
NCT00227500 | HIV Infections ... More >> Lipid Metabolism Glucose Metabolism Metabolic Abnormality Lipodystrophy Cardiovascular Disease Less << | Phase 4 | Completed | - | Australia, New South Wales ... More >> St. Vincents Hospital Sydney, New South Wales, Australia, 2010 Less << |
NCT00840177 | Leukemia | Phase 2 | Active, not recruiting | July 2019 | - |
NCT01903694 | Child-Pugh A Hepatocellular Ca... More >>rcinoma Less << | Phase 3 | Completed | - | France ... More >> CHU de Dijon Dijon, France, 21079 Less << |
NCT00257686 | - | Completed | - | - | |
NCT00117494 | Hyperlipidemia ... More >> HIV Infections Less << | Phase 4 | Completed | - | France ... More >> service de Médecine Interne Hopital Hotel Dieu Paris, France, 75004 Less << |
NCT01602913 | - | Completed | - | - | |
NCT00221754 | HIV Infection ... More >> Hypercholesterolemia Less << | Phase 2 | Completed | - | France ... More >> Hôpital Saint André, Service de médecine interne et maladies infectieuses Bordeaux, France, 33000 Less << |
NCT00688896 | Type II Hyperlipidemia | Phase 2 | Completed | - | Netherlands ... More >> Amsterdam, Netherlands Less << |
NCT02360826 | Drug Distribution | Phase 1 | Completed | - | United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less << |
NCT00006412 | HIV Infections ... More >> Lipodystrophy Less << | Phase 3 | Completed | - | - |
NCT00688922 | Acute Myocardial Infarction | Phase 4 | Unknown | June 2011 | Japan ... More >> Kansai Rosai Hospital Recruiting Amagasaki, Hyogo, Japan Contact: Shinsuke Nanto, MD/PhD 81-6-6416-1221 Principal Investigator: Shinnsuke Nanto, MD/PhD Higashi-Osaka City General Hospital Recruiting Higashi-Osaka, Osaka, Japan Contact: Yoshiyuki Kijima, MD/PhD Principal Investigator: Yoshiyuki Kijima, MD/PhD Kawachi General Hospital Recruiting Higashi-Osaka, Osaka, Japan Contact: Masayoshi Mishima, MD/PhD Principal Investigator: Masayoshi Mishima, MD/PhD Osaka Minami Medical Center, National Hospital Organization Recruiting Kawachinagano, Osaka, Japan Contact: Tatsuya Sasaki, MD/PhD Principal Investigator: Tatsuya Sasaki, MD/PhD Osaka Rosai Hospital Recruiting Sakai, Osaka, Japan Contact: Masami Nishino, MD/PhD Principal Investigator: Masami Nishino, MD/PhD Osaka University Hospital Recruiting Suita, Osaka, Japan, 565-0871 Contact: Yasuhiko Sakata, MD/PhD 81-6-6879-6612 sakatayk@medone.med.osaka-u.ac.jp Principal Investigator: Yasuhiko Sakata, MD/PhD Osaka General Medical Center Not yet recruiting Osaka, Japan Contact: Masatake Fukunami, MD/PhD Principal Investigator: Masatake Fukunami, MD/PhD Osaka Police Hospital Recruiting Osaka, Japan Contact: Yasunori Ueda, MD/PhD 81-6-6771-6051 Principal Investigator: Yasunori Ueda, MD/PhD Sakurabashi Watanabe Hospital Not yet recruiting Osaka, Japan Contact: Hiroshi Ito, MD/PhD Contact: Motoo Date, MD/PhD Principal Investigator: Hiroshi Ito, MD/PhD Sub-Investigator: Motoo Date, MD/PhD Less << |
NCT01256476 | Primary Dyslipidemia ... More >> Mixed Dyslipidemia Less << | Phase 4 | Completed | - | - |
NCT01256476 | - | Completed | - | - | |
NCT01958489 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Leeds, West Yorkshire, United Kingdom, LS2 9LH Less << |
NCT02547402 | Acute Kidney Injury | Phase 1 | Completed | - | United States, Michigan ... More >> Jasper Clinical Research & Development, Inc. Kalamazoo, Michigan, United States, 49007 Less << |
NCT00916747 | Progeria | Phase 2 | Enrolling by invitation | July 2020 | United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less << |
NCT00599625 | Crohn's Disease | Not Applicable | Unknown | December 2011 | United States, Virginia ... More >> University of Virginia Recruiting Charlottesville, Virginia, United States, 22908 Contact: Brian Behm, MD 434-924-2959 bwb2c@virginia.edu Contact: Meredith Gross 434-924-2753 mpg8b@virginia.edu Principal Investigator: Brian Behm, MD Less << |
NCT03456102 | Tuberculosis | Phase 2 | Not yet recruiting | September 1, 2021 | - |
NCT01057654 | Hypercholesterolemia ... More >> Hyperlipoproteinemia Less << | Phase 3 | Completed | - | Germany ... More >> Dept. of Clinical Pharmacology, University of Bonn Bonn, Germany, 53105 Less << |
NCT01872845 | Coronary Artery Occlusive Dise... More >>ase Less << | Not Applicable | Unknown | May 2018 | Korea, Republic of ... More >> Severance Hospital Recruiting Seoul, Korea, Republic of, 120-752 Contact: MyeongKi Hong, MD, PhD 82-2-2228-8460 mkhong61@yuhs.ac Less << |
NCT00755352 | Hypercholesterolemia | Phase 4 | Completed | - | United States, California ... More >> Los Angeles, California, United States United States, Colorado Castle Rock, Colorado, United States United States, Florida Jacksonville, Florida, United States Pembroke Pines, Florida, United States St. Petersburg, Florida, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Kentucky Louisville, Kentucky, United States United States, New York Rochester, New York, United States United States, Ohio Cincinnati, Ohio, United States Cleveland, Ohio, United States United States, Tennessee Bartlett, Tennessee, United States United States, Virginia Norfolk, Virginia, United States Richmond, Virginia, United States United States, Washington Seattle, Washington, United States Less << |
NCT00834847 | Healthy | Phase 1 | Completed | - | Canada, Ontario ... More >> Pharma Medica Research Inc. Toronto, Ontario, Canada, M1R 5A3 Less << |
NCT01958489 | - | Completed | - | - | |
NCT01075555 | Liver Cancer | Phase 3 | Completed | - | France ... More >> Hopital Du Bocage Dijon, France, 21000 Less << |
NCT00382460 | Actue Coronary Syndromes | Phase 4 | Completed | - | - |
NCT02166593 | Combined Dyslipidemia | Phase 3 | Completed | - | Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of Less << |
NCT01325818 | Coronary Disease ... More >> Hypercholesterolemia Less << | Phase 4 | Unknown | February 2016 | Japan ... More >> Yokohama City University Medical Center Recruiting Yokohama, Japan Contact: Kenichiro Saka 81-45-261-5656 Ken_saka@yokohama-cu.ac.jp Principal Investigator: Kenichiro Saka Less << |
NCT00702130 | Ventilator Associated Pneumoni... More >>a Less << | Early Phase 1 | Completed | - | Greece ... More >> General Hospital Larissa Larissa, Thessalia, Greece, 41221 Zakynthinos E. Dir-University Hospital Larisa Mezourlo / Larissa, Greece, 41110 Less << |
NCT00834379 | Healthy | Phase 1 | Completed | - | Canada, Ontario ... More >> Pharma Medica Research Inc. Toronto, Ontario, Canada, M1R 5A3 Less << |
NCT00731016 | Hutchinson-Gilford Progeria Sy... More >>ndrome Less << | Phase 2 | Completed | - | France ... More >> Laboratoire de Génétique Moléculaire - Hopital de la Timone Marseille, France, 13385 Less << |
NCT03219372 | Hepatocellular Carcinoma ... More >> Liver Cirrhoses Less << | Phase 2 | Recruiting | June 1, 2022 | United States, California ... More >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Shehnaz Hussain, PhD 310-423-6401 Shehnaz.Hussain@cshs.org Contact: Sandra Contreras 424-315-2216 sandra.contreras@cshs.org Sub-Investigator: Walid Ayoub, MD Sub-Investigator: Marc Goodman, PhD Sub-Investigator: Mazen Noureddin, MD Sub-Investigator: Laura Kulik, MD Sub-Investigator: Vatche Agopian, MD Sub-Investigator: Richard Finn, MD Sub-Investigator: David Lu, MD Sub-Investigator: Otoniel Martinez-Maza, PhD Less << |
NCT01038154 | Esophageal Cancer ... More >> Stomach Cancer Less << | Phase 4 | Unknown | November 2012 | Spain ... More >> Department Gastroenterology. Hospital Donostia Recruiting San Sebastián, Guipúzcoa, Spain, 20014 Contact: Luis Bujanda, Prof. 34-943007173 luis.bujanda@osakidetza.net Less << |
NCT00630734 | HIV Infections ... More >> Hyperlipidemia Less << | Phase 4 | Completed | - | United States, Colorado ... More >> University of Colorado Denver Aurora, Colorado, United States, 80045 Less << |
NCT01268202 | Fibrosis | Phase 2 | Unknown | July 2016 | France ... More >> Centre Val d'Aurelle Not yet recruiting Montpellier, France, 34298 Contact: David AZRIA, MD Principal Investigator: David AZRIA, MD Hôpital Européen Georges Pompidou Not yet recruiting Paris, France, 75015 Contact: Philippe GIRAUD, MD Principal Investigator: Philippe GIRAUD, MD Institut Gustave Roussy Recruiting Villejuif, France, 94805 Contact: Céline BOURGIER, MD, PhD 33 1 42 11 49 31 bourgier@igr.fr Contact: Anne AUPERIN, MD, PhD 33 1 42 11 54 99 auperin@igr.fr Principal Investigator: Céline BOURGIER, MD, PhD Less << |
NCT00665717 | HIV Infections | Phase 1 | Completed | - | Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands Less << |
NCT02754739 | Diabetes Mellitus ... More >> Prediabetic State Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul, Korea, Republic of, 135-710 Less << |
NCT00630734 | - | Completed | - | - | |
NCT02079974 | Endometriosis | Not Applicable | Withdrawn | - | Canada, Ontario ... More >> Mount Sinai Hospital, University of Toronto Toronto, Ontario, Canada, M5G 1X5 Less << |
NCT00650221 | Therapeutic Equivalency | Phase 1 | Completed | - | Canada, Ontario ... More >> Biovail Contract Research Toronto, Ontario, Canada, M1L 4S4 Less << |
NCT02992548 | Chronic Kidney Disease | Phase 4 | Active, not recruiting | August 2018 | Korea, Republic of ... More >> Dong-A University Busan, Korea, Republic of, 602715 Inje University, Pusan Paik Hospital Busan, Korea, Republic of Less << |
NCT01418729 | Advanced Hepatocarcinoma | Phase 2 | Completed | - | Spain ... More >> Hospital Donostia, Instituto Biodonostia San Sebastian, Gipuzkoa, Spain, 20014 Less << |
NCT00459745 | Combined Hyperlipidemia | Phase 3 | Completed | - | - |
NCT01254461 | Drug Interaction | Phase 1 | Completed | - | Sweden ... More >> Research Site Uppsala, Sweden Less << |
NCT00879034 | - | Completed | - | - | |
NCT00879034 | Progeria Hutc... More >>hinson-Gilford Syndrome Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less << |
NCT02621957 | Breast Cancer | Phase 1 | Completed | - | United States, Florida ... More >> Daytona Beach, Florida, United States, 32117 Less << |
NCT01497483 | Healthy | Phase 1 | Completed | - | United States, California ... More >> San Francisco General Hosptail San Francisco, California, United States, 94110 Less << |
NCT01342887 | Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Less << | Phase 1 Phase 2 | Terminated | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT01342887 | - | Terminated | - | - | |
NCT00571194 | End Stage Renal Disease | Phase 1 | Terminated | - | United States, Arkansas ... More >> Arkansas Children's Hospital Little Rock, Arkansas, United States, 72202 Less << |
NCT00571194 | - | Terminated | - | - | |
NCT01831232 | - | Completed | - | - | |
NCT00830258 | Healthy | Phase 1 | Completed | - | Canada, Ontario ... More >> Pharma Medica Research Inc. Toronto, Ontario, Canada, M1R 5A3 Less << |
NCT01082588 | - | Completed | - | - | |
NCT00829309 | Healthy | Phase 1 | Completed | - | United States, North Dakota ... More >> PRACS Institute, Ltd. Fargo, North Dakota, United States, 58104 Less << |
NCT01831232 | Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Refractory Anemia With Excess Blasts Untreated Adult Acute Myeloid Leukemia Less << | Not Applicable | Completed | - | United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less << |
NCT00829309 | - | Completed | - | - | |
NCT00830258 | - | Completed | - | - | |
NCT01146093 | Healthy | PHASE1 | COMPLETED | 2025-03-03 | - |
NCT01146106 | Healthy | PHASE1 | COMPLETED | 2025-12-02 | - |
NCT00648544 | Therapeutic Equivalency | Phase 1 | Completed | - | Canada, Ontario ... More >> Biovail Contract Reseach Toronto, Ontario, Canada, M1L 4S4 Less << |
NCT03648970 | Pre-Eclampsia | Phase 2 | Recruiting | December 1, 2020 | Indonesia ... More >> Sanglah General Hospital Not yet recruiting Denpasar, Bali, Indonesia Contact: Ryan Saktika Mulyana, MD, OBGYN ryanmul83@gmail.com Principal Investigator: Ryan Saktika Mulyana, MD, OBGYN Sub-Investigator: Evert Pangkahila, MD, OBGYN Dr. Moewardi Hospital Not yet recruiting Surakarta, Central Java, Indonesia, 57126 Contact: Muhammad Adrianes Bachnas, MD, OBGYN +628122692928 bachnasadri@gmail.com Principal Investigator: Muhammad Adrianes Bachnas, MD, OBGYN Sub-Investigator: Eric Edwin, MD, OBGYN Ramelan Naval Hospital Not yet recruiting Surabaya, East Java, Indonesia, 60244 Contact: Agung Sunarko Putra, MD, OBGYN +62811257852 dr.agung_sp@yahoo.com Principal Investigator: Agung Sunarko Putra, MD, OBGYN Sub-Investigator: Frans OH Prasetyadi, MD, OBGYN Dr. Soetomo Hospital Recruiting Surabaya, East Java, Indonesia, 60285 Contact: Muhammad Ilham Aldika Akbar, MD, OBGYN +6281703270900 dokter_aldi@yahoo.com Adam Malik General Hospital Not yet recruiting Medan, North Sumatra, Indonesia Contact: Dudy Aldiansyah dudya141277@gmail.com Principal Investigator: Dudy Aldiansyah, MD, OBGYN Sub-Investigator: Makmur Sitepu, MD, OBGYN Dr. Wahidin Sudirohusodo General Hospital Not yet recruiting Makasar, South Sulawesi, Indonesia Contact: Deviana Soraya Riu, MD, OBGYN virayariu@gmail.com Principal Investigator: Deviana Soraya Riu, MD, OBGYN Sub-Investigator: Ellen Theresia Wawengkang, MD, OBGYN Hasan Sadikin General Hospital Recruiting Bandung, West Java, Indonesia Contact: Muhammad Alamsyah Azis, MD, Obgyn alamsyahaziz9119@gmail.com Principal Investigator: Muhammad Alamsyah Azis, MD, Obgyn Sub-Investigator: Johanes Cornelius Mose, MD, OBGYN Less << |
NCT01082588 | Schizophrenia ... More >> Schizoaffective Disorders Schizophreniform Disorders Less << | Phase 4 | Completed | - | United States, Massachusetts ... More >> Freedom Trail Clinic Boston, Massachusetts, United States, 02114 Less << |
NCT01717586 | Preeclampsia | Phase 1 | Recruiting | April 2019 | United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Katherine Wisner, MD 312-926-2323 Katherine.Wisner@northwestern.edu Contact: Minaz Kolia, MD 312-695-7190 minaz.kolia@northwestern.edu United States, Pennsylvania University of Pittsburgh Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Steve Caritis, MD 412-641-4874 scaritis@mail.magee.edu Contact: Dawn Fischer, RN 412-641-5194 dfischer@mail.magee.edu Principal Investigator: Steve Caritis, MD United States, Texas University of Texas Medical Branch Recruiting Galveston, Texas, United States, 77555 Contact: Maged Costantine, MD 409-772-1571 mmcostan@utmb.edu Contact: Holly West, PA-C 409-747-8234 hawest@utmb.edu Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.24mL 0.45mL 0.22mL |
11.20mL 2.24mL 1.12mL |
22.40mL 4.48mL 2.24mL |
|
Dissolving Methods |
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:
in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day; The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
|